MedPath

湖南尔康制药股份有限公司

Ownership
-
Established
2003-10-22
Employees
665
Market Cap
-
Website
http://www.erkangpharma.com

Clinical Trials

0

Active:0
Completed:0

Trial Phases

0 Phases

Drug Approvals

241

NMPA:241

Drug Approvals

Vitamin B₆ Injection

Product Name
维生素B6注射液
Approval Number
国药准字H20258096
Approval Date
May 30, 2025
NMPA

Piroxicam Tablets

Product Name
吡罗昔康片
Approval Number
国药准字H43021505
Approval Date
Sep 20, 2024
NMPA

Vitamin B Complex Tablets

Product Name
复合维生素B片
Approval Number
国药准字H43021126
Approval Date
Sep 20, 2024
NMPA

Erythromycin Enteric-coated Tablets

Product Name
红霉素肠溶片
Approval Number
国药准字H43021460
Approval Date
Sep 20, 2024
NMPA

Metamizole Sodium Tablets

Product Name
安乃近片
Approval Number
国药准字H43021497
Approval Date
Sep 20, 2024
NMPA

Acetylspiramycin Tablets

Product Name
乙酰螺旋霉素片
Approval Number
国药准字H43021083
Approval Date
Sep 20, 2024
NMPA

Hymecromone Capsules

Product Name
羟甲香豆素胶囊
Approval Number
国药准字H43020800
Approval Date
Sep 20, 2024
NMPA

Piroxicam Tablets

Product Name
吡罗昔康片
Approval Number
国药准字H43021504
Approval Date
Sep 20, 2024
NMPA

Naproxen Tablets

Product Name
萘普生片
Approval Number
国药准字H43021561
Approval Date
Sep 20, 2024
NMPA

Naproxen Tablets

Product Name
萘普生片
Approval Number
国药准字H43021562
Approval Date
Sep 20, 2024
NMPA
  • Prev
  • 1
  • 2
  • 3
  • 4
  • 5
  • 25
  • Next

Clinical Trials

No trials found

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.